3 completed, 1 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Zymar: new trials by email Literature Review of Zymar trials Research Report on Zymar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. Pazufloxacin, Zymar - Conjunctivitis, Bacterial | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 46 | 2018-10-01 | 2021-08-24 |
| Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects Besifloxacin hydrochloride, moxifloxacin hydrochloride, gatifloxacin - Cataract Extraction | Phase 1 | Completed | Bausch & Lomb Incorporated | 105 | 2009-02-01 | 2011-12-13 |
| Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation 0.3% gatifloxacin and 1.0% prednisolone acetate association, isolated 0.3% gatifloxacin and 1.0% prednisolone acetate - Ocular Infection and Inflammation | Phase 3 | Completed | Federal University of São Paulo | 101 | 2009-01-01 | 2018-03-21 |
| One Hour Preoperative Gatifloxacin Zymar - Ophthalmic Surgery | Phase 4 | Completed | Stanford University | 60 | 2007-01-01 | 2015-01-29 |
Conjunctivitis, Bacterial (1) · Eye Infections (1) · Inflammation (1)
Bausch & Lomb Incorporated (1) · Federal University of São Paulo (1) · Laboratorios Sophia S.A de C.V. (1) · Stanford University (1)
United States (2) · Brazil (1) · Mexico (1)
Christopher Ta, MD (1) · Eric Donnefeld (1)